Israel’s TytoCare has just received FDA clearance so physicians can use its remote examination kit to accurately diagnose lung conditions in adults and children aged two and above.
TytoCare’s service links patients with healthcare professionals so they can monitor, diagnose, and treat patients virtually. Its service enables people to self-conduct examinations of the heart, lungs, skin, throat, and ears as well as temperature readings from anywhere at any time, supplying healthcare providers with the clinical data they need.
The new algorithm automatically analyzes lung sounds recorded by the handheld device’s stethoscope to determine whether a patient is wheezing.
“Our Tyto Insight capabilities, including our wheeze detection algorithm, furthers our goal of enhancing the virtual care experience for all patients, clinicians, providers, and health plans – not just by increasing the quality of care and expanding our chronic care management capabilities, but also by further assisting clinicians and specialists to make informed and accurate diagnoses remotely,” said Dedi Gilad, CEO and Co-Founder of TytoCare.